IBDEI14Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18254,1,2,0)
 ;;=2^TRIM NONDYSTROPHIC NAILS
 ;;^UTILITY(U,$J,358.3,18254,1,3,0)
 ;;=3^11719
 ;;^UTILITY(U,$J,358.3,18255,0)
 ;;=10021^^89^917^17^^^^1
 ;;^UTILITY(U,$J,358.3,18255,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18255,1,2,0)
 ;;=2^FNA w/o Imaging Guidance,1st Lesion
 ;;^UTILITY(U,$J,358.3,18255,1,3,0)
 ;;=3^10021
 ;;^UTILITY(U,$J,358.3,18256,0)
 ;;=10004^^89^917^18^^^^1
 ;;^UTILITY(U,$J,358.3,18256,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18256,1,2,0)
 ;;=2^FNA w/o Imaging Guidance,Ea Addl Lesion
 ;;^UTILITY(U,$J,358.3,18256,1,3,0)
 ;;=3^10004
 ;;^UTILITY(U,$J,358.3,18257,0)
 ;;=G0109^^89^918^1^^^^1
 ;;^UTILITY(U,$J,358.3,18257,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18257,1,2,0)
 ;;=2^DIAB MGMT TRN,GRP PER 30MIN
 ;;^UTILITY(U,$J,358.3,18257,1,3,0)
 ;;=3^G0109
 ;;^UTILITY(U,$J,358.3,18258,0)
 ;;=98960^^89^918^3^^^^1
 ;;^UTILITY(U,$J,358.3,18258,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18258,1,2,0)
 ;;=2^SELF-MGMT EDUC & TRAIN 1 PT
 ;;^UTILITY(U,$J,358.3,18258,1,3,0)
 ;;=3^98960
 ;;^UTILITY(U,$J,358.3,18259,0)
 ;;=G0108^^89^918^2^^^^1
 ;;^UTILITY(U,$J,358.3,18259,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18259,1,2,0)
 ;;=2^DIAB MGMT TRN,IND PER 30MIN
 ;;^UTILITY(U,$J,358.3,18259,1,3,0)
 ;;=3^G0108
 ;;^UTILITY(U,$J,358.3,18260,0)
 ;;=98961^^89^918^4^^^^1
 ;;^UTILITY(U,$J,358.3,18260,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18260,1,2,0)
 ;;=2^SELF-MGMT EDUC & TRAIN 2-4 PTS
 ;;^UTILITY(U,$J,358.3,18260,1,3,0)
 ;;=3^98961
 ;;^UTILITY(U,$J,358.3,18261,0)
 ;;=98962^^89^918^5^^^^1
 ;;^UTILITY(U,$J,358.3,18261,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18261,1,2,0)
 ;;=2^SELF-MGMT EDUC & TRAIN 5-8 PTS
 ;;^UTILITY(U,$J,358.3,18261,1,3,0)
 ;;=3^98962
 ;;^UTILITY(U,$J,358.3,18262,0)
 ;;=90707^^89^919^21^^^^1
 ;;^UTILITY(U,$J,358.3,18262,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18262,1,2,0)
 ;;=2^MMR VACCINE
 ;;^UTILITY(U,$J,358.3,18262,1,3,0)
 ;;=3^90707
 ;;^UTILITY(U,$J,358.3,18263,0)
 ;;=90714^^89^919^25^^^^1
 ;;^UTILITY(U,$J,358.3,18263,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18263,1,2,0)
 ;;=2^TD VACCINE
 ;;^UTILITY(U,$J,358.3,18263,1,3,0)
 ;;=3^90714
 ;;^UTILITY(U,$J,358.3,18264,0)
 ;;=90732^^89^919^22^^^^1
 ;;^UTILITY(U,$J,358.3,18264,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18264,1,2,0)
 ;;=2^PNEUMOCOCCAL VACCINE 23 VALENT
 ;;^UTILITY(U,$J,358.3,18264,1,3,0)
 ;;=3^90732
 ;;^UTILITY(U,$J,358.3,18265,0)
 ;;=90662^^89^919^5^^^^1
 ;;^UTILITY(U,$J,358.3,18265,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18265,1,2,0)
 ;;=2^FLU VACC HIGH DOSE SYR (FLUZONE)
 ;;^UTILITY(U,$J,358.3,18265,1,3,0)
 ;;=3^90662
 ;;^UTILITY(U,$J,358.3,18266,0)
 ;;=90736^^89^919^29^^^^1
 ;;^UTILITY(U,$J,358.3,18266,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18266,1,2,0)
 ;;=2^ZOSTER (SHINGLES) VACCINE
 ;;^UTILITY(U,$J,358.3,18266,1,3,0)
 ;;=3^90736
 ;;^UTILITY(U,$J,358.3,18267,0)
 ;;=90670^^89^919^24^^^^1
 ;;^UTILITY(U,$J,358.3,18267,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18267,1,2,0)
 ;;=2^PREVNAR 13
 ;;^UTILITY(U,$J,358.3,18267,1,3,0)
 ;;=3^90670
 ;;^UTILITY(U,$J,358.3,18268,0)
 ;;=90686^^89^919^8^^^^1
 ;;^UTILITY(U,$J,358.3,18268,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18268,1,2,0)
 ;;=2^FLU VACC SGLE DOSE SYR (FLUARIX)
 ;;^UTILITY(U,$J,358.3,18268,1,3,0)
 ;;=3^90686
 ;;^UTILITY(U,$J,358.3,18269,0)
 ;;=90688^^89^919^6^^^^1
 ;;^UTILITY(U,$J,358.3,18269,1,0)
 ;;=^358.31IA^3^2
